跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
和美新 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Topotecan Hydrochloride for Injection
Approved
化学药品
Topotecan Hydrochloride for Injection
Sandoz Pharmaceuticals AG
🇨🇳 National Medical Products Administration
Approval Date
Jan 12, 2023
Approval ID
4eb282adae289cee
Company
Sandoz Pharmaceuticals AG
Type
化学药品
Approval Details
Approval Id
4eb282adae289cee
Approval Number
国药准字HJ20181105
Generic Name
注射用盐酸托泊替康
Generic Name En
Topotecan Hydrochloride for Injection
Trade Name
和美新
Drug Type
化学药品
Dosage Form
注射剂
Strength
1mg
Reg Date
2023-01-12
Expired Date
2028-01-11
Company Name
Sandoz Pharmaceuticals AG
Company Address
Suurstoffi 14 CH-6343 Rotkreuz Switzerland
Production Company Name
glaxosmithkline manufacturing s.p.a.
Production Company Address
Strada Provinciale Asolana 90, 43056 San Polo di Torrile, Parma, Italy
Company Detail Path
/organization/sandoz-pharmaceuticals-ag
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jan 12, 2023
Approval ID
4eb282adae289cee
Type
化学药品
Back to NMPA Approvals